Viewing Study NCT06552650



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06552650
Status: RECRUITING
Last Update Posted: None
First Post: 2024-02-28

Brief Title: Evaluating the Effectiveness of an Early Exercise Program After Breast Reconstruction
Sponsor: None
Organization: None

Study Overview

Official Title: Randomized Controlled Study to Evaluate the Effect of Early Exercise on Functional Restoration of Exercise and Surgical Outcomes After Breast Reconstruction
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Breast reconstruction is an important step and option after mastectomy and can help improve the quality of life of breast cancer patients Therefore the proportion of patients undergoing breast reconstruction in conjunction with mastectomy is steadily increasing Despite recent advances in less invasive techniques postoperative movement restrictions are unavoidable and these postoperative pain or functional limitations can last for months to years Patients most often experience a decrease in shoulder function which negatively impacts their physical function and is an important factor in their ability to perform activities of daily living Early postoperative exercise has been proven to have positive results in promoting the recovery of shoulder function in breast cancer patient However there is a lack of research on the effectiveness of early postoperative exercise in the context of breast reconstruction Therefore this study aims to evaluate the effect of early postoperative exercise on patients shoulder and trunk function after breast reconstruction
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None